3 Fast Growing US Stocks Investors Are Screening For Insider Backing

Simply Wall St.12:43

Cooling US inflation expectations and softer wage growth have taken some pressure off interest rate fears, which pushes investors to look again at companies where insiders already have serious skin in...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2658607471?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-08-10 12:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658607471","market":"sg","top_or_hot":-1,"title":"3 Fast Growing US Stocks Investors Are Screening For Insider Backing","media":"Simply Wall St.","content":"<div>\n<p>Cooling US inflation expectations and softer wage growth have taken some pressure off interest rate fears, which pushes investors to look again at companies where insiders already have serious skin in...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/3-fast-growing-us-stocks-investors-are-screening-for-insider\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Fast Growing US Stocks Investors Are Screening For Insider Backing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Fast Growing US Stocks Investors Are Screening For Insider Backing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-10 12:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/3-fast-growing-us-stocks-investors-are-screening-for-insider><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cooling US inflation expectations and softer wage growth have taken some pressure off interest rate fears, which pushes investors to look again at companies where insiders already have serious skin in...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/3-fast-growing-us-stocks-investors-are-screening-for-insider\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/3-fast-growing-us-stocks-investors-are-screening-for-insider","article_id":"2658607471","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/3-fast-growing-us-stocks-investors-are-screening-for-insider","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2658607471","pubTimestamp":1786336995,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Cooling US inflation expectations and softer wage growth have taken some pressure off interest rate fears, which pushes investors to look again at companies where insiders already have serious skin in the game. That combination of a calmer macro backdrop and high insider conviction can be powerful for growth focused investors who dislike feeling late to the story. This article highlights 3 fast growing stocks with high insider ownership from the screener.\nThe stocks covered below are only a...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4139":"生物科技","SPHQ":"Invesco S&P 500 Quality ETF","ISBC":"投资者银行","BK4575":"芯片概念","ACMR":"Acm Research Inc.","SOXY":"YieldMax Target 12 Semiconductor Option Income ETF","LU0052750758.USD":"富兰克林中国基金A Acc","XITK":"SPDR FactSet Innovative Technology ETF","BK4505":"高瓴资本持仓","QTOC":"Innovator Growth Accelerated Plus ETF - October","AIPO":"Defiance AI and Power Infrastructure ETF","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","PGEN":"Precigen","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK4588":"碎股","AGIX":"通用人工智能 ETF-AGIX","BK4147":"半导体设备","ARTY":"ISHARES FUTURE AI & TECH ETF","VTHR":"Vanguard Russell 3000 ETF","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","BK4211":"区域性银行"},"translate_title":"投资者正在筛选 3 只快速增长的美国股票以寻求内部人士支持","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XITK":0.6,"QTOC":0.64,"ARTY":0.64,"AIPO":0.64,"SPHQ":0.64,"CHAT":0.64,"ISBC":1.5,"ACMR":1,"VTHR":0.73,"SOXY":0.6,"PGEN":1,"AGIX":0.64},"content_text":"Cooling US inflation expectations and softer wage growth have taken some pressure off interest rate fears, which pushes investors to look again at companies where insiders already have serious skin in the game. That combination of a calmer macro backdrop and high insider conviction can be powerful for growth focused investors who dislike feeling late to the story. This article highlights 3 fast growing stocks with high insider ownership from the screener. The stocks covered below are only a small sample, as the full screen surfaced 1,301 more companies with high insider alignment and growth profiles that are not covered here but offer similarly compelling stories to investigate. If you want to quickly sort through those ideas and focus on the ones that fit your style, head straight into the Fast Growing Stocks With High Insider Ownership screener. AdvertisementPrecigen (PGEN) Overview: Precigen is a Germantown based biopharmaceutical company that develops gene and cell therapies for cancer, autoimmune conditions and infectious diseases, built around its AdenoVerse gene delivery and UltraCAR T cell platforms. It focuses on patients with high unmet medical need, including hard to treat blood cancers, solid tumors, HPV+ diseases and recurrent respiratory papillomatosis. Operations: Precigen currently generates about US$86 million in revenue from its biotechnology segment, with almost all of it coming from the United States. Market Cap: US$2.6b Precigen stands out in this screener because it already has a commercial product, PAPZIMEOS, that is gaining traction in a previously underserved adult recurrent respiratory papillomatosis market, backed by seven year US market exclusivity through 2032 and expanding payer coverage. Recent quarterly results showed strong PAPZIMEOS driven revenue and a move into quarterly profitability, while management is targeting cash flow break even by the end of 2026 if momentum continues. At the same time, the company still carries a short cash runway, relies on external funding and has seen insider selling and shareholder dilution, which raises questions about how comfortably it can fund its growth plans. For investors, the combination of early commercial progress, high expectations for expansion and meaningful financing risk makes Precigen a company that some market participants may monitor closely. Precigen’s early commercial traction and progress toward cash flow break even suggest that the story is only half told. Get the full picture, including 1 key reward and 3 important warning signs NasdaqGS:PGEN Earnings & Revenue History as at Aug 2026 Build your own high conviction growth shortlist Precigen and the two other stocks in this article all came from a single screen, but the real value comes when you shape the filters yourself. Use our customisable Screener to mix growth, valuation, balance sheet and risk filters, or jump straight into any of our curated Investing Ideas for ready made starting points. ACM Research (ACMR) Overview: ACM Research is a Fremont based semiconductor equipment company that supplies cleaning, electroplating, furnace and advanced packaging tools used in making complex chips, with a strong footprint in China and a growing presence across Asia and the US. Market Cap: US$5.8b ACM Research is worth a close look if you are interested in the picks and shovels behind AI and high end chip production. The company sells wet cleaning, electroplating and advanced packaging tools that chipmakers use for 3D NAND, DRAM and logic nodes. Q2 2026 results showed strong revenue momentum from plating, furnace and packaging platforms along with raised full year guidance. At the same time, heavy dependence on China, high R&D spend and funding growth with external borrowing leave earnings and cash flow exposed if demand or export rules shift. For investors, the key consideration is whether the mix of strong product traction and a higher risk balance sheet provides sufficient potential reward in ACM Research’s long term story. ACM Research sits at the intersection of AI chip demand and a balance sheet that leans on borrowing. Get the full story in the 4 key rewards and 2 important warning signs (2 are major!) NasdaqGM:ACMR Earnings & Revenue Growth as at Aug 2026 AppLovin (APP) Overview: AppLovin runs an AI powered advertising platform that helps app developers, brands and content companies find and monetize users across mobile and connected TV, supported by its own portfolio of apps. Its tools span campaign management, real time ad auctions, measurement and analytics, along with streaming distribution for TV content owners. Operations: AppLovin currently generates about US$6.8b in revenue from its Advertising segment, split roughly evenly between the United States and the rest of the world. Market Cap: US$116.1b AppLovin may be of interest if you are looking at AI powered picks and shovels for digital advertising rather than trying to select the next hit app. The AXON platform sits at the core of its offering, supporting revenue and earnings growth and very high profitability, and large buybacks have already retired roughly 23% of shares under the current program. At the same time, heavy reliance on mobile gaming, high leverage and exposure to tighter privacy rules and big tech platforms leave limited room for missteps, as illustrated by the sharp share price reaction after Q2’s revenue miss. For investors, a key question is whether the company’s earnings power, AI capabilities and growing e commerce footprint sufficiently balance those execution and balance sheet risks. AppLovin’s AI engine, substantial share repurchase program and strong margins create a powerful story that many investors only see on the surface. The real twist appears once you study the analyst forecasts for AppLovin NasdaqGS:APP Earnings & Revenue Growth as at Aug 2026 Seeking Fresh Alternatives For Your Watchlist New opportunities move fast. Fresh ideas gain momentum, quiet stories turn into breakouts and under the radar stocks get caught once the crowd arrives. Check these screens and act now.  Spot income workhorses before yields start dropping by scanning the 8 dividend fortresses while they are still flying under most investors' radar. Hunt for off the beaten path quality by checking the 21 high quality undiscovered gems that pair solid fundamentals with stories many investors have not fully priced in yet. Position ahead of the next automation wave by reviewing the curated 37 robotics and automation stocks before industrial and AI themes pull these stocks into the spotlight.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2658607471","isCrawlerRequest":true}